GET THE APP
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr. Carl Balibar is an Investigator at the Novartis Institutes for BioMedical Research (NIBR) working to discover and develop novel antibiotics against medically important bacterial pathogens. He received his Ph.D. in Biological Chemistry and Molecular Pharmacology from Harvard University. Supported by both National Science Foundation (NSF) and National Defense Science and Engineering Graduate (NDSEG) research fellowships, he studied the biosynthesis of various biologically active natural products under the guidance of Dr. Christopher T. Walsh. He joined the Infectious Diseases department at NIBR as a postdoctoral fellow in 2007 where he studied various facets of bacterial physiology. He has authored numerous papers in the fields of enzymology and bacteriology and is a member of the American Society for Microbiology (ASM).
Natural product biosynthesis
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals